Clinical pharmacology and human antitumor activity of cytosine arabinoside.
D000230:Adenocarcinoma / Q000188:drug therapy; D001792:Blood Platelets; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D006452:Hemoglobinometry; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007958:Leukocyte Count; D008223:Lymphoma / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy
D003561:Cytarabine